The Chemours Company — Third Quarter 2026 Earnings Summary

The Chemours Company reported third-quarter 2026 net sales of $1.54 billion, representing a 3% year-over-year increase driven by pricing actions in Titanium Technologies and growth in Advanced Performance Materials. Net income attributable to the company rose to $196 million, or $1.29 per diluted share, compared to $46 million in the prior-year quarter, while adjusted EBITDA increased to $200 million. The company finalized a settlement with the State of North Carolina regarding PFAS litigation and completed the sale of its Kuan Yin property for approximately $340 million. Looking ahead, the company forecasts fourth-quarter net sales to decline by 5% to 10% sequentially, with full-year 2026 net sales expected to grow approximately 2% over 2025.